Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Pareyson

Showing results (81-90 of 231) with videos related to

Pageof 24
Sort By:
Journal of the Peripheral Nervous System : JPNS|May 28, 2016
Screening for SH3TC2 gene mutations in a series of demyelinating recessive Charcot-Marie-Tooth disease (CMT4)Giuseppe Piscosquito, Paola Saveri, Stefania Magri, et al.
European Journal of Neurology|May 9, 2025
Split Hand Syndrome in Charcot-Marie-Tooth Disease Type X1 (CMTX1): A Clinical, Neurophysiological, and Radiological StudyAlessandro Bertini, Marco Moscatelli, Claudia Ciano, et al.
Neurology|May 9, 2014
Expanding sialidosis spectrum by genome-wide screening: NEU1 mutations in adult-onset myoclonusLaura Canafoglia, Angela Robbiano, Davide Pareyson, et al.
Brain : a Journal of Neurology|May 10, 2014
PMP22 messenger RNA levels in skin biopsies: testing the effectiveness of a Charcot-Marie-Tooth 1A biomarkerLucilla Nobbio, Davide Visigalli, Davide Radice, et al.
Journal of the Peripheral Nervous System : JPNS|March 19, 2008
Correlation between clinical/neurophysiological findings and quality of life in Charcot-Marie-Tooth type 1ALuca Padua, Michael E Shy, Irene Aprile, et al.
Pharmacological Research|October 13, 2006
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol [EudraCT no.: 2006-000032-27]Davide Pareyson, Angelo Schenone, Gian Maria Fabrizi, et al.
Neurology|May 3, 2015
A slowly progressive mitochondrial encephalomyopathy widens the spectrum of AIFM1 disordersAnna Ardissone, Giuseppe Piscosquito, Andrea Legati, et al.
Brain : a Journal of Neurology|November 8, 2025
Charcot-Marie-Tooth-SORD: insights into pathology and pathophysiology from a human nerve biopsy seriesMaike F Dohrn, Davide Pareyson, Chiara Pisciotta, et al.
Orphanet Journal of Rare Diseases|October 6, 2018
The Italian neuromuscular registry: a coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usageAnna Ambrosini, Daniela Calabrese, Francesco Maria Avato, et al.
Journal of the Neurological Sciences|December 21, 2010
Lower limb areflexia without central and peripheral conduction abnormalities is highly suggestive of Gerstmann-Sträussler-Scheinker disease Pro102LeuEttore Salsano, Roberto Fancellu, Giuseppe Di Fede, et al.
Pageof 24

Showing results (81-90 of 231) with videos related to

Sort By:
Pageof 24
Journal of the Peripheral Nervous System : JPNS|May 28, 2016
Screening for SH3TC2 gene mutations in a series of demyelinating recessive Charcot-Marie-Tooth disease (CMT4)Giuseppe Piscosquito, Paola Saveri, Stefania Magri, et al.
European Journal of Neurology|May 9, 2025
Split Hand Syndrome in Charcot-Marie-Tooth Disease Type X1 (CMTX1): A Clinical, Neurophysiological, and Radiological StudyAlessandro Bertini, Marco Moscatelli, Claudia Ciano, et al.
Neurology|May 9, 2014
Expanding sialidosis spectrum by genome-wide screening: NEU1 mutations in adult-onset myoclonusLaura Canafoglia, Angela Robbiano, Davide Pareyson, et al.
Brain : a Journal of Neurology|May 10, 2014
PMP22 messenger RNA levels in skin biopsies: testing the effectiveness of a Charcot-Marie-Tooth 1A biomarkerLucilla Nobbio, Davide Visigalli, Davide Radice, et al.
Journal of the Peripheral Nervous System : JPNS|March 19, 2008
Correlation between clinical/neurophysiological findings and quality of life in Charcot-Marie-Tooth type 1ALuca Padua, Michael E Shy, Irene Aprile, et al.
Pharmacological Research|October 13, 2006
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol [EudraCT no.: 2006-000032-27]Davide Pareyson, Angelo Schenone, Gian Maria Fabrizi, et al.
Neurology|May 3, 2015
A slowly progressive mitochondrial encephalomyopathy widens the spectrum of AIFM1 disordersAnna Ardissone, Giuseppe Piscosquito, Andrea Legati, et al.
Brain : a Journal of Neurology|November 8, 2025
Charcot-Marie-Tooth-SORD: insights into pathology and pathophysiology from a human nerve biopsy seriesMaike F Dohrn, Davide Pareyson, Chiara Pisciotta, et al.
Orphanet Journal of Rare Diseases|October 6, 2018
The Italian neuromuscular registry: a coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usageAnna Ambrosini, Daniela Calabrese, Francesco Maria Avato, et al.
Journal of the Neurological Sciences|December 21, 2010
Lower limb areflexia without central and peripheral conduction abnormalities is highly suggestive of Gerstmann-Sträussler-Scheinker disease Pro102LeuEttore Salsano, Roberto Fancellu, Giuseppe Di Fede, et al.
Pageof 24